Managers / Q2 2024 · view latest →
Greystone Financial Group, LLC
CIK 0001845302 · 665 HULET DR, BLOOMFIELD HILLS, MI, 48302 · (248) 267-1270
Summary
Greystone Financial Group, LLC reported $511M in U.S.-listed holdings across 99 positions for Q2 2024.
Its largest position, Vanguard Bd Index Fds, represents 6.6% of the portfolio.
Compared with Q1 2024, the fund opened 7 new positions and exited 12.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 63.1% · $323M
- ETP · 32.1% · $164M
- REIT · 2.6% · $13M
- ADR · 2.0% · $10M
- Other · 0.2% · $872,354
Quarter-over-Quarter Changes full breakdown →
vs Q1 2024 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ISHARES TR | NEW | +125.6K | 125.6K | +$13M | $13M |
| FOXAFOX CORP | NEW | +217.6K | 217.6K | +$7M | $7M |
| PLDPROLOGIS INC. | NEW | +57.8K | 57.8K | +$6M | $6M |
| 7HPHP INC | NEW | +182.8K | 182.8K | +$6M | $6M |
| BBYBEST BUY INC | NEW | +48.0K | 48.0K | +$4M | $4M |
| INVESCO ACTVELY MNGD ETC FD | NEW | +32.4K | 32.4K | +$455,684 | $455,684 |
| VRTXVERTEX PHARMACEUTICALS INC | NEW | +895 | 895 | +$419,504 | $419,504 |
| ISHARES TR | ADDED | +130.3K | 136.0K | +$7M | $7M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q2 2024
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $353M | 78 | Apr 24, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $641M | 97 | Jan 27, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $645M | 100 | Oct 22, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $607M | 94 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $551M | 99 | Apr 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $575M | 95 | Feb 3, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $560M | 102 | Oct 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $511M | 99 | Aug 6, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $501M | 104 | Apr 22, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $432M | 104 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $401M | 104 | Nov 1, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $431M | 106 | Jul 18, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $397M | 94 | Apr 25, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $340M | 71 | Jan 23, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $295M | 67 | Oct 25, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $321M | 68 | Aug 3, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $396M | 81 | May 2, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $417M | 84 | Feb 1, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $336M | 83 | Nov 3, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $402M | 86 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $398M | 84 | May 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $367M | 98 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.